Andrew Stewart Plump, President, R&D at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 116,191 shares at $18.49 ($2.1M) on 2026-09-02, disclosed to the SEC on 2026-09-03.
Scheduled sale ($2.1M) by President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |